Barrett's esophagus: Treatments of adenocarcinomas II Conference Paper
| Authors: | Twaddell, W. S.; Wu, P. C.; Verhage, R. J.; Feith, M.; Ilson, D. H.; Schuhmacher, C. P.; Luketich, J. D.; Brücher, B.; Vallböhmer, D.; Hofstetter, W. L.; Krasna, M. J.; Kandioler, D.; Schneider, P. M.; Wijnhoven, B. P.; Sontag, S. J. |
| Title: | Barrett's esophagus: Treatments of adenocarcinomas II |
| Conference Title: | 10th Congress of the World Organization for Specialized Studies on Diseases of the Esophagus (OESO) |
| Abstract: | The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer. © 2011 New York Academy of Sciences. |
| Keywords: | cancer chemotherapy; protein expression; treatment response; survival analysis; survival rate; mortality; cisplatin; fluorouracil; cancer combination chemotherapy; capecitabine; paclitaxel; cancer adjuvant therapy; cancer radiotherapy; combined modality therapy; cancer staging; drug megadose; positron emission tomography; sentinel node; antineoplastic agent; lymph node dissection; sentinel lymph node; sentinel lymph node biopsy; lymphadenectomy; adenocarcinoma; cell proliferation; low drug dose; radiotherapy; epidermal growth factor receptor; epidermal growth factor receptor 2; practice guideline; mutational analysis; protein p53; cancer mortality; docetaxel; irinotecan; monoclonal antibody; intraoperative period; gefitinib; esophagus resection; epirubicin; minimally invasive surgery; robotics; adenovirus vector; neoadjuvant chemotherapy; egfr; cancer classification; esophagus cancer; esophageal adenocarcinoma; frozen section; life expectancy; chemoradiation; esophageal neoplasms; chemoradiotherapy; esophageal cancer; p53; her2; adenoviridae; molecular markers; residual disease; multimodality therapy; sentinel lymph nodes; folfox; ivor lewis esophagectomy; barrett esophagus; robotic surgery; minimally invasive esophagectomy; r0 resection; 5-fu; aeg; barrett's esophagus; fdg pet scan; gamma probe; high risk patients; integrated pet/ct scan; pet tracer; robot assisted thoracolaparoscopic esophagectomy; siewert 's classification; submucosal invasion; two-stade esophagectomy; siewert classification |
| Journal Title | Annals of the New York Academy of Sciences |
| Volume: | 1232 |
| Issue: | 1 |
| Conference Dates: | 2010 Aug 28-31 |
| Conference Location: | Boston, MA |
| ISBN: | 0077-8923 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2011-09-01 |
| Start Page: | 265 |
| End Page: | 291 |
| Language: | English |
| DOI: | 10.1111/j.1749-6632.2011.06056.x |
| PROVIDER: | scopus |
| PUBMED: | 21950818 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 November 2011" - "CODEN: ANYAA" - "Source: Scopus" |
